Trial Profile
A study investigating the effect of eculizumab in treating thrombotic microangiopathic anemia in patients who received non-renal solid organ transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Thrombotic microangiopathy
- Focus Therapeutic Use
- 23 Dec 2015 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 01 Nov 2013 Recruitment completed according to results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.